Drugs & medicalClass III

Zydus Pharmaceuticals (USA) Inc recalls Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufactured by: Zydus…

Labeling: Not Elsewhere Classified - Wrong NDC number

Read the official notice →
Date
2024-12-11
Country
United States
Brand
Zydus Pharmaceuticals
Product
Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufactured by: Zydus Lifesciences…
Classification
Class III
Units
USA Nationwide.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Zydus Pharmaceuticals recalls

  1. 2025-04-16
  2. US
    Drugs & medicalClass II

    Zydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi,…

    CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA,…Official notice →
  3. US
    Drugs & medicalClass II

    Zydus Pharmaceuticals (USA) Inc recalls Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus…

    Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.

    FDA · DrugZydus Pharmaceuticals (USA) IncUS Nationwide.Official notice →
  4. 2025-03-12
  5. US
  6. 2024-07-31
  7. US
    Drugs & medicalClass II

    Zydus Pharmaceuticals (USA) Inc recalls Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and…

    Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide within the United StatesOfficial notice →
  8. 2024-07-24
  9. US
  10. 2024-07-17
  11. US
    Drugs & medicalClass III

    Zydus Pharmaceuticals (USA) Inc recalls Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India,…

    Cross contamination with other products

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide in the USA and Puerto RicoOfficial notice →
All 26 Zydus Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2024-12-11
  2. US
    Drugs & medicalClass II

    AvKARE recalls Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-460-30

    CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.

    FDA · DrugAvKAREUSA NationwideOfficial notice →
  3. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99)…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit

    FDA · DrugRising Pharma Holding, Inc.Nationwide.Official notice →
  4. US
  5. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottle, Manufactured by: Aurobindo Pharma Limited,…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit

    FDA · DrugAmerisource Health Services LLCPA, OH, PROfficial notice →
  6. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules, USP 90mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for:…

    cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwide in the USAOfficial notice →
  7. US
    Drugs & medicalClass II

    Midlab Incorporated recalls ROYALAB Germ Away Antibacterial Hand Soap, Chloroxylenol 0.1%, NET CONTENTS: ONE U.S. GALLON (3.78 L), Royal Papers, 2701 Hereford St.,…

    cGMP Deviations: Out of specification results for micro in hand soap products.

    FDA · DrugMidlab IncorporatedNationwide in the USAOfficial notice →
See all drugs & medical recalls →